JSCZX | NAESX | JSCZX / NAESX | |
Total Expense Ratio | 1.49 | 0.17 | 876% |
Annual Report Gross Expense Ratio | 1.49 | 0.17 | 876% |
Fund Existence | 13 years | 65 years | - |
Gain YTD | -8.914 | -5.833 | 153% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 892M | 153B | 1% |
Annual Yield % from dividends | 0.00 | 1.39 | - |
Returns for 1 year | -13.13 | 1.18 | -1,117% |
Returns for 3 years | -12.06 | 6.44 | -187% |
Returns for 5 years | 40.48 | 115.68 | 35% |
Returns for 10 years | -10.85 | 90.61 | -12% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
JETD | 20.08 | 4.21 | +26.52% |
MAX Airlines -3X Inverse Leveraged ETN | |||
THW | 11.26 | -0.01 | -0.09% |
abrdn World Healthcare Fund | |||
IBHI | 22.83 | -0.36 | -1.55% |
iShares iBonds 2029 Term HY & Inc ETF | |||
FMED | 22.95 | -0.62 | -2.62% |
Fidelity Disruptive Medicine ETF | |||
ESML | 36.53 | -2.70 | -6.88% |
iShares ESG Aware MSCI USA Small-Cap ETF |